Denver/Overland Park, Kan. -- A three-year, $1 million project seeking to prevent, treat and cure cancer in dogs.
Denver/Overland Park, Kan.
-- The Golden Retriever Foundation and Morris Animal Foundation have teamed up to fund a new major cancer study. Titled "Discovery and characterization of heritable and somatic cancer mutations in Golden Retrievers," the three-year, $1 million project will get started this summer.
The project is part of Morris Animal Foundation's Canine Cancer Campaign, a worldwide effort to prevent, treat and ultimately cure the disease in dogs. The study will be led by researchers from the University of Minnesota, North Carolina State University, the Broad Institute of MIT and Harvard, and Uppsala University in Sweden.
Researchers will investigate mutations involved in the two most common cancers affecting Golden Retrievers: hemangiosarcoma and lymphoma. According to the Morris Animal Foundation, the study could benefit humans too, since genes involved in cancer are sometimes the same in both species.
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More